Millipore Sigma Vibrant Logo

539572 Serine/Threonine Kinase Inhibitor Set - Calbiochem

View This Product on Sigma-Aldrich
539572
価格&在庫状況を照会

概要

Replacement Information

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
539572-1SETCN
在庫状況検索中…
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      ガラスビン 1 set
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      Description
      OverviewA convenient set that offers several highly selective serine/threonine kinase inhibitors. Set contains 250 µg of protein kinase C inhibitor, Bisindolylmaleimide I (Cat. No. 203290); 1 mg of protein kinase A inhibitor, H-89, Dihydrochloride (Cat. No. 371963); 1 mg of PKG inhibitor, Protein Kinase G Inhibitor (Cat. No. 370654); 1 mg of MLCK inhibitor, ML-7 (Cat. No. 475880); 1 mg of CaM kinase II inhibitor, KN-93 (Cat. No. 422708); and 100 µg of the broad range Serine/Threonine Kinase inhibitor, Staurosporine (Cat. No. 569397). Supplied with a data sheet.
      Catalogue Number539572
      Brand Family Calbiochem®
      Application Data
      References
      ReferencesMartiny, G., et al. 1993. J. Biol. Chem. 268, 9194.
      Toullec, D., et al. 1991. J. Biol. Chem. 266, 15771.
      Chijiwa, T., et al. 1990. J. Biol. Chem. 265, 5267.
      Simu, M., et al. 1991. Biochem. Biophys. Res. Commun. 181, 968.
      Saitoh, M., et al. J. Biol. Chem. 262, 7796.
      Glass, D.B., et al. 1983. Biochem. J. 213, 159.
      Seynaeve, C.M., et al. 1994. Mol. Pharmacol. 45, 1207.
      Meyer, T., et al. 1989. Int. J. Cancer 43, 851.
      Product Information
      FormSolid
      Hygroscopic Hygroscopic
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetPKA
      Secondary targetPKC, MLCK, Cam kinase II, PKG
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 23/25-36/37/38-45-63

      Toxic by inhalation and if swallowed.
      Irritating to eyes, respiratory system and skin.
      May cause cancer.
      Possible risk of harm to the unborn child.
      S PhraseS: 22-36/37/39-45-53

      Do not breathe dust.
      Wear suitable protective clothing, gloves and eye/face protection.
      In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
      Avoid exposure - obtain special instructions before use.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Multiple Toxicity Values, refer to MSDS
      Storage -20°C
      Protect from Light Protect from light
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions of each inhibitor are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      539572-1SETCN 04055977194715

      Documentation

      Serine/Threonine Kinase Inhibitor Set - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      Serine/Threonine Kinase Inhibitor Set - Calbiochem 試験成績書(CoA)

      タイトルロット番号
      539572

      参考資料

      参考資料の概要
      Martiny, G., et al. 1993. J. Biol. Chem. 268, 9194.
      Toullec, D., et al. 1991. J. Biol. Chem. 266, 15771.
      Chijiwa, T., et al. 1990. J. Biol. Chem. 265, 5267.
      Simu, M., et al. 1991. Biochem. Biophys. Res. Commun. 181, 968.
      Saitoh, M., et al. J. Biol. Chem. 262, 7796.
      Glass, D.B., et al. 1983. Biochem. J. 213, 159.
      Seynaeve, C.M., et al. 1994. Mol. Pharmacol. 45, 1207.
      Meyer, T., et al. 1989. Int. J. Cancer 43, 851.

      カタログ

      タイトル
      Protein Kinase Assay and Detection Kits Brochure
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision14-September-2007 JSW
      Application Data
      DescriptionA convenient set that offers several highly selective serine/threonine kinase inhibitors. Kinases play an important role in numerous signaling cascades. Highly selective protein kinase inhibitors are useful for dissecting these cascades to determine which specific kinases are involved in producing particular biological effects. The Serine/Threonine Kinase Inhibitor Set contains the following highly selective serine/ threonine kinase inhibitors in one convenient set:

      • Bisindolylmaleimide I (Cat. No. 203290), 250 µg
      • H-89, Dihydrochloride (Cat. No. 371963), 1 mg
      • KN-93 (Cat. No. 422708), 1 mg
      • ML-7 (Cat. No. 475880), 1 mg
      • Protein Kinase G Inhibitor (Cat. No. 370654), 1 mg
      • Staurosporine (Cat. No. 569397), 100 µg
      FormSolid
      SolubilityH₂O (1 mg/ml; Protein Kinase G Inhibitor)
      DMSO (1 mg/ml; all other inhibitors)
      Storage Protect from light
      -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions of each inhibitor are stable for up to 3 months at -20°C.
      Toxicity Multiple Toxicity Values, refer to MSDS
      ReferencesMartiny, G., et al. 1993. J. Biol. Chem. 268, 9194.
      Toullec, D., et al. 1991. J. Biol. Chem. 266, 15771.
      Chijiwa, T., et al. 1990. J. Biol. Chem. 265, 5267.
      Simu, M., et al. 1991. Biochem. Biophys. Res. Commun. 181, 968.
      Saitoh, M., et al. J. Biol. Chem. 262, 7796.
      Glass, D.B., et al. 1983. Biochem. J. 213, 159.
      Seynaeve, C.M., et al. 1994. Mol. Pharmacol. 45, 1207.
      Meyer, T., et al. 1989. Int. J. Cancer 43, 851.